Climb Bio, Inc.

Climb Bio, Inc.verified

CLYM

Price:

$1.73

Market Cap:

$117.96M

Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Industry

Biotechnology

IPO Date

2021-08-10

Stock Exchange

NASDAQ

Ticker

CLYM

The PE Ratio as of December 2025 (TTM) for Climb Bio, Inc. (CLYM) is -2.93

According to Climb Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.93. This represents a change of -28.78% compared to the average of -4.11 of the last 4 quarters.

Climb Bio, Inc. (CLYM) Historical PE Ratio (quarterly & annually)

How has CLYM PE Ratio performed in the past?

The mean historical PE Ratio of Climb Bio, Inc. over the last ten years is -5.36. The current -2.93 PE Ratio has changed 5.37% with respect to the historical average. Over the past ten years (40 quarters), CLYM's PE Ratio was at its highest in in the March 2025 quarter at -0.99. The PE Ratio was at its lowest in in the March 2024 quarter at -31.88.

Quarterly (TTM)
Annual

Average

-5.36

Median

-4.49

Minimum

-13.95

Maximum

-1.17

Climb Bio, Inc. (CLYM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Climb Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 125.21%

Maximum Annual PE Ratio = -1.17

Minimum Annual Increase = -80.50%

Minimum Annual PE Ratio = -13.95

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.17-80.50%
2023-6.0232.14%
2022-4.55125.21%
2021-2.02-54.23%
2020-4.42-68.32%

Climb Bio, Inc. (CLYM) Average PE Ratio

How has CLYM PE Ratio performed in the past?

The current PE Ratio of Climb Bio, Inc. (CLYM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.91

5-year avg

-3.64

10-year avg

-5.36

Climb Bio, Inc. (CLYM) PE Ratio vs. Peers

How is CLYM’s PE Ratio compared to its peers?

Climb Bio, Inc.’s PE Ratio is greater than Entera Bio Ltd. (-39.70), less than Spero Therapeutics, Inc. (-2.93), less than Seres Therapeutics, Inc. (29.07), greater than Anixa Biosciences, Inc. (-17.38), less than Acumen Pharmaceuticals, Inc. (-0.90), less than Inovio Pharmaceuticals, Inc. (-0.00), greater than Actuate Therapeutics Inc (-6.52), less than Turn Therapeutics Inc. (0), less than VistaGen Therapeutics, Inc. (-2.46), less than Agenus Inc. (-0.69),

Build a custom stock screener for Climb Bio, Inc. (CLYM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Climb Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Climb Bio, Inc. (CLYM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Climb Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Climb Bio, Inc.'s PE Ratio?

How is the PE Ratio calculated for Climb Bio, Inc. (CLYM)?

What is the highest PE Ratio for Climb Bio, Inc. (CLYM)?

What is the 3-year average PE Ratio for Climb Bio, Inc. (CLYM)?

What is the 5-year average PE Ratio for Climb Bio, Inc. (CLYM)?

How does the current PE Ratio for Climb Bio, Inc. (CLYM) compare to its historical average?